Research & Development

Neuroscience is deeply rooted within Ipsen as a key strategic driver for our business. Through our strategy in external innovation, we are actively expanding our pipeline into neurodegenerative disorders .

€2869.9 M

Total sales 2021
+12.3 % YOY

€2153.5 M

2021 Oncology sales
+10.8 % YOY

35.2%

Record core
operating margin

€440.7 M

2021 Rare disease sales
-10.4% YOY